BioMarin Pharmaceutical | Vermögenswerte



Assets Veränderung Datum
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 89.37B 2.47B 2025-03
Bayer EUR 109.18B 1.67B 2025-03
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Incyte USD 5.82B 71.99M 2025-06
Insmed USD 1.8B 222.5M 2025-03
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 132.8B 3.04B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
United Therapeutics USD 7.91B 164.1M 2025-06
Vertex Pharmaceuticals USD 22.88B 347.3M 2025-03


BioMarin Pharmaceutical Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.